title: Cilostazol for peripheral arterial disease could reduce stroke risk?
authors.affiliation: Northern Vascular Centre, Freeman Hospital, Newcastle upon Tyne, NE7 7DN, UK.
authors.forename: A
authors.initials: A
authors.lastname: Watson
authors.forename: D P
authors.initials: DP
authors.lastname: Mikhailidis
authors.forename: G
authors.initials: G
authors.lastname: Stansby
mesh_terms: D000077407:Cilostazol; D005260:Female; D006801:Humans; D008297:Male; D058729:Peripheral Arterial Disease / Q000188:drug therapy*; D020521:Stroke / Q000517:prevention & control*; D013777:Tetrazoles / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
chemical_list: D013777:Tetrazoles; D014665:Vasodilator Agents; D000077407:Cilostazol